Cover Image
Market Research Report

Cell Viability Assays and Consumables: Global Markets

Published by BCC Research Product code 824924
Published Content info 203 Pages
Delivery time: 1-2 business days
Price
Back to Top
Cell Viability Assays and Consumables: Global Markets
Published: April 17, 2019 Content info: 203 Pages
Description

Report Highlights:

The global market for cell viability assays should grow from $2.7 billion in 2018 to reach $4.1 billion by 2023 at a compound annual growth rate (CAGR) of 8.3% for the period of 2018-2023.

Consumables as a segment of cell viability assays market should grow from $1.6 billion in 2018 to reach $2.4 billion by 2023 at a CAGR of 8.7% for the period of 2018-2023.

Instruments as a segment of cell viability assays should grow from $1.1 billion in 2018 to reach $1.6 billion by 2023 at a CAGR of 7.6% for the period of 2018-2023.

Report Scope:

The scope of this report is broad and covers various types of products available in the cell viability assays market and potential application sectors in various industries. The cell viability assays market is broken down by product into instruments and consumables. Revenue forecasts from 2018 to 2023 are given for each product, application, cell type and end user, with estimated valued derived from the revenues of manufacturers. Revenue generated from the installation and maintenance of instruments has been excluded from the report.

The report also includes a discussion of the major players in each regional cell viability assays market. Further, it explains the major drivers and regional dynamics of the global market and current trends within the industry.

The report concludes with a special focus on the vendor landscape and includes detailed profiles of the major players in the global cell viability assays market.

Report Includes:

  • 95 data tables and 66 additional tables
  • An overview of the global cell viability assays market
  • Analyses of global market trends, with data from 2017, 2018, and projections of compound annual growth rates (CAGRs) through 2023
  • Information on various type of products available in the cell viability assays market and potential applications across various industries
  • Examination of the main product applications and markets in an effort to help companies and investors prioritize product opportunities and strategic movements
  • Evaluation of key industry and market trends, and quantification of the main market segments, allowing the reader to better understand the industry's structure and changes occurring within it
  • Coverage of innovations and development in stem cell research, toxicity testing and tissue engineering
  • Insight into regulatory framework and investment analysis in the healthcare sector
  • Detailed profiles of the major players of the industry, including Bio-Rad Laboratories Inc., Danaher Corp., GE Healthcare, Merck KGaA and R&D Systems Inc.
Table of Contents
Product Code: BIO181A

Table of Contents

Chapter 1: Introduction

  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Information Sources
  • Methodology
  • Geographic Breakdown
  • Analyst's Credentials
  • BCC Custom Research
  • Related BCC Research Reports

Chapter 2: Summary and Highlights

Chapter 3: Market Overview

  • Introduction
  • Market Potential
    • Market Size and Growth
    • Consumer Types and Product Success
    • Competitor Pricing
  • Regulatory Framework
    • United States
    • European Union
    • China
    • India
    • Japan
    • Australia
    • Brazil
    • Russia
  • Investment Analysis
  • Industry Growth Drivers
    • Increasing Focus on Development of Cell-Based Therapeutics and Potential Biomarkers
    • Growing Prevalence and Incidence of Infectious and Chronic Diseases
    • Increasing Demand for Cell-Based Assays in Research and Development
    • Increasing Emphasis on Stem Cell Research

Chapter 4: Cell Viability Assays Market by Product

  • Instruments
    • Automated Cell Counters
    • Flow Cytometers
    • Spectrophotometers
    • Cell Imaging and Analysis Systems
  • Consumables
    • Reagents
    • Assay Kits
    • Microplates

Chapter 5: Market Breakdown by Cell Type

  • Human Cells
    • Assays to Measure Viable Cells
    • Benefits of Protease Marker Assays
    • Advantages of ATP Assays
    • ATP Cell Viability Assay for Measuring Intrinsic Radio-Sensitivity in Cervical Cancer
  • Animal Cells
    • Advantages of Viability Assays for Animals
  • Microbial Cells
    • Cell Viability Assay to Determine the Cytotoxic Effects by Microbes in Water
    • Imaging Microbial Viability Assays
    • Imaging Biofilm Viability Assays
    • Bacterial Viability Assays for Flow Cytometry
    • Viability Detection of Foodborne Microbial Pathogens
    • Global Estimates of Foodborne Diseases

Chapter 6: Market Breakdown by Application

  • Clinical and Diagnostic Applications
  • Drug Discovery and Development
  • Stem Cell Research
    • Potential Benefits of Stem Cell Research
    • Basic Research
  • Other Applications (e.g., Toxicity Testing, Tissue Engineering)
    • Toxicity Testing
    • Tissue Engineering

Chapter 7: Market Breakdown by End User

  • Academic and Research Institutions
    • Market Drivers
  • Pharmaceutical and Biotechnology Companies
    • UV-Spectrophotometers for Drug Stability Testing
    • Market Drivers
  • Hospitals and Diagnostic Laboratories
    • Cell Viability Assays
    • Assays and Their Substrates
    • Technological Advancements and Innovations
    • XTT Formazan Assay to Detect Cell Viability Inhibits HIV Type 1 Infection
    • Viability Assay to Identify Biologically-Relevant Malaria Transmission- Blocking Drugs
    • Assays for Diagnostic Tests for Malaria
    • Non-Blood Based Assays
    • Blood-Based Assays
  • Other End Users
    • Cancer Diagnosis and Prognosis

Chapter 8: Market Breakdown by Region

  • North America
    • United States
    • Canada
  • Europe
    • United Kingdom
    • France
    • Germany
    • Spain
    • Rest of Europe
  • Asia-Pacific Region
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia-Pacific
  • Rest of the World
    • Latin America
    • Middle East and Africa

Chapter 9: Cell Viability Assays Market Industry Structure

  • Raw Material Suppliers
    • Quality and Technology
    • Terms and Conditions
    • Cost-Effective Components
  • Manufacturers
  • Distributors
  • Raw Material Suppliers of Consumables
    • Quality
    • Terms and Conditions
    • Cost
  • Manufacturers of Consumables
  • Distributors of Consumables
  • End Users of Consumables
  • Innovation Within the Industry
  • Competitive Analysis

Chapter 10: Company Profiles

  • AAT BIOQUEST INC.
  • ABCAM
  • ABNOVA CORP.
  • ANASPEC INC.
  • BECTON, DICKINSON AND CO.
  • BIO-RAD LABORATORIES
  • BIOTEK INSTRUMENTS
  • BIOTIUM
  • BIOVISION INC.
  • CAYMAN CHEMICAL
  • CORNING INC.
  • CREATIVE BIOARRAY
  • DANAHER CORP.
  • DOJINDO MOLECULAR TECHNOLOGIES INC.
  • GE HEALTHCARE
  • INTELLICYT CORP.
  • MERCK KGAA
  • MESGEN
  • MOLECULAR DEVICES LLC
  • PERKINELMER
  • PROMEGA CORP.
  • R&D SYSTEMS INC.
  • TAKARA BIO INC.
  • THERMO FISHER SCIENTIFIC
  • VITASCIENTIFIC

List of Tables

  • Summary Table: Global Cell Viability Assays Market, by Product, Through 2023
    • Table 1: Manufacturer and Distributor Product Pricing Comparison
    • Table 2: Examples of Requirements for UV-Visible Spectrophotometers
    • Table 3: Classes of Biologicals
    • Table 4: Cell Viability Assay Market: Key Recent Investments
    • Table 5: Recent Studies in Cell-Based Therapeutics
    • Table 6: NIH Funding Estimates for Various Conditions and Diseases, 2014-2019
    • Table 7: Leading Causes of Burden of Diseases around the World, 2004 and 2030
    • Table 8: Worldwide Cancer Incidence Rate, 2018
    • Table 9: Global Pharmaceutical R&D Spending, 2015-2022
    • Table 10: Pharmaceutical Research and Manufacturers of America Member Company R&D Expenditures, 2010 and 2016
    • Table 11: Investments in Stem Cell Research
    • Table 12: Global Cell Viability Assays Market, by Product, Through 2023
    • Table 13: Global Cell Viability Assays Instruments Market, by Type, Through 2023
    • Table 14: Global Cell Viability Assays Instruments Market, by Region, Through 2023
    • Table 15: Global Automated Cell Counters Market, by Region, Through 2023
    • Table 16: Global Flow Cytometers Market, by Region, Through 2023
    • Table 17: Feature-wise Comparison of Conventional Flow Cytometry and Imaging Flow Cytometry
    • Table 18: Key Analytical Parameters Measured by Flow Cytometers in Cell Viability Research
    • Table 19: Global Spectrophotometers Market, by Region, Through 2023
    • Table 20: Types of Spectrophotometers for Cell Viability Analysis
    • Table 21: Global Cell Imaging and Analysis Systems Market, by Region, Through 2023
    • Table 22: Global Cell Viability Assays Consumables Market, by Type, Through 2023
    • Table 23: Global Cell Viability Assays Consumables Market, by Region, Through 2023
    • Table 24: Global Reagents Market, by Region, Through 2023
    • Table 25: Library Screening of Small-Molecule Cancer Cells by Deploying Real-Time Cell Viability Assays
    • Table 26: List of Applications of Reagents for Drug Discovery
    • Table 27: List of Research Laboratories Using Reagents for Cell Viability Testing
    • Table 28: Global Assay Kits Market, by Region, Through 2023
    • Table 29: Global Assay kits Market, by Type, Through 2023
    • Table 30: MTT and XTT Kits Comparison
    • Table 31: Cost-effective Cell Viability Assays Through In Vitro Cell Screening and Cell Death Discrimination
    • Table 32: Procedure for Quantification of Cell Number Through MTT Assays
    • Table 33: Key Benefits and Features of XTT Assay Kits Over Radioactive Isotope Techniques
    • Table 34: List of Recently-Developed Chymotrypsin and Homogeneous Trypsin Protease Assays, 2017
    • Table 35: Global Microplates Market, by Region, Through 2023
    • Table 36: Funding for Various Projects in Life Sciences Research, 2017-2026
    • Table 37: Innovation Project Funds for BRAIN 2025 Priority Verticals
    • Table 38: Global Cell Viability Assays Market, by Cell Type, Through 2023
    • Table 39: Global Human Cells Market, by Region, Through 2023
    • Table 40: Rate of New Cancer Cases, 2018
    • Table 41: Global Deaths Due to Cancer, 2018
    • Table 42: Global Oncology Therapeutics Investment, 2011-2021
    • Table 43: Global Animal Cells Market, by Region, Through 2023
    • Table 44: Intracellular Assays to Measure Cellular Proliferation
    • Table 45: Global Microbial Cells Market, by Region, Through 2023
    • Table 46: Regional Foodborne Disease, 2016
    • Table 47: Global Cell Viability Assays Market, by Application, Through 2023
    • Table 48: Global Clinical and Diagnostic Applications Market, by Region, Through 2023
    • Table 49: Global Cancer Burden, 2012 and 2030
    • Table 50: Global Prevalence of Dementia, 2015-2050
    • Table 51: Global Pharmaceutical Market, 2015 and 2020
    • Table 52: Pharmaceutical Spending as a Percentage of Health Spending, by Country, 2016
    • Table 53: Global Biologics Spending, 2011 and 2016
    • Table 54: Global Drug Discovery and Development Market, by Region, Through 2023
    • Table 55: Global Total Pharmaceutical R&D Spending, 2015-2022
    • Table 56: Description of Government Support for Development of New Treatments in Organizations, by Country
    • Table 57: Global Stem Cell Research Market, by Region, Through 2023
    • Table 58: Application of Stem Cells in Regenerative Medicines
    • Table 59: NIH Spending on Stem Cell Research, 2014-2018 (Estimated)
    • Table 60: Growing Investment in Different Areas of Stem Cell-Based Research in the United States, 2016 and 2017
    • Table 61: Ongoing Clinical Diabetes-Based Stem Cell Research
    • Table 62: Ongoing Clinical Leukemia-Based Stem Cell Research
    • Table 63: Global Basic Research Market, by Region, Through 2023
    • Table 64: Top U.S. Academic Institutions Spending on R&D, 2018
    • Table 65: Global Others Application Market, by Region, Through 2023
    • Table 66: Funded Projects Supporting Tissue Engineering Solutions in Cancer Research
    • Table 67: Global Cell Viability Assays Market, by End User, Through 2023
    • Table 68: Global Academic and Research Institutions Market, by Region, Through 2023
    • Table 69: Current Cancer Research Grants, by Type, 2018
    • Table 70: Global Pharmaceutical and Biotechnology Companies Market, by Region, Through 2023
    • Table 71: Pharmaceutical R&D Spending by U.S., 2005-2015
    • Table 72: R&D Spending by Seven Pharma Giants in India, 2016
    • Table 73: Global Hospital and Diagnostic Laboratories in Cell Viability Assays Market, by Region, Through 2023
    • Table 74: Death Rates Due to Cancer, 2018
    • Table 75: People Infected with HIV, by Region, 2014-2016
    • Table 76: Malaria Deaths, by Region, 2014-2016
    • Table 77: Global Others End User Market, by Region, Through 2023
    • Table 78: Clinical Applications of Flow Cytometry
    • Table 79: Various Cancer Research Programs
    • Table 80: Selected Fluorescent Dyes for Specific Staining in Flow Cytometry Applications in Food Microbiology
    • Table 81: Global Cell Viability Assays Market, by Region, Through 2023
    • Table 82: North American Cell Viability Assays Market, by Country, Through 2023
    • Table 83: North American Cell Viability Assays Market, by Type, Through 2023
    • Table 84: North American Cell Viability Assays Market, by Application, Through 2023
    • Table 85: North American Cell Viability Assays Market, by End User, Through 2023
    • Table 86: North American Cell Viability Assays Market, by Product, Through 2023
    • Table 87: NIH Spending on Stem Cell Research, 2013-2016
    • Table 88: Healthcare Expenditures in Canada, 2015 and 2040
    • Table 89: Distribution of Annual Budget of Canadian Institutes of Health Research, 2016
    • Table 90: European Cell Viability Assays Market, by Country, Through 2023
    • Table 91: European Cell Viability Assays Market, by Product, Through 2023
    • Table 92: European Cell Viability Assays Market, by End User, Through 2023
    • Table 93: European Cell Viability Assays Market, by Type, Through 2023
    • Table 94: European Cell Viability Assays Market, by Application, Through 2023
    • Table 95: Estimated Number of People Living with Cancer, 2015 and 2020
    • Table 96: Deaths from and Number of People Living with Heart and Circulatory Diseases in the United Kingdom, 2016
    • Table 97: Government Funding for Drug-Based Research in France, 2010 and 2016
    • Table 98: Rising Number of Cancer Cases in Spain, 2012 and 2015
    • Table 99: Hospitals and Research Centers Participating in Clinical Trials on Cancer, 2004-2016
    • Table 100: Rising Prevalence of Breast Cancer in Norway, 2014 and 2015
    • Table 101: Asia-Pacific Cell Viability Assays Market, by Country, Through 2023
    • Table 102: Asia-Pacific Cell Viability Assays Market, by Product, Through 2023
    • Table 103: Asia-Pacific Cell Viability Assays Market, by Type, Through 2023
    • Table 104: Asia-Pacific Cell Viability Assays Market, by End User, Through 2023
    • Table 105: Asia-Pacific Cell Viability Assays Market, by Application, Through 2023
    • Table 106: Number of People with Cancer in China, 2010-2016
    • Table 107: Growth in Japanese Pharmaceuticals Industry, 2010-2015
    • Table 108: R&D Spending by Top Seven Pharmaceutical Companies in India, 2016
    • Table 109: Overall ROW R&D Expenditures, by Region, 2016 and 2017
    • Table 110: Rest of the World Cell Viability Assays Market, by Region, Through 2023
    • Table 111: Rest of the World Cell Viability Assays Market, by Application, Through 2023
    • Table 112: Rest of the World Cell Viability Assays Market, by Type, Through 2023
    • Table 113: Rest of the World Cell Viability Assays Market, by End User, Through 2023
    • Table 114: Rest of the World Cell Viability Assays Market, by Product, Through 2023
    • Table 115: Deaths in Brazil Due to Cancer, by Type, 2010 and 2016
    • Table 116: Prevalence of Cancer in Brazil, by Type, 2010 and 2016
    • Table 117: Capital Raised by Israeli High-Tech Companies, 2013-2017
    • Table 118: Raw Material/Part Manufacturers
    • Table 119: Manufacturers Operating in the Cell Assays Market
    • Table 120: Distributors Operating in the Cell Assays Market
    • Table 121: Raw Material/Part Manufacturers
    • Table 122: Manufacturers Operating in the Cell Assays Market
    • Table 123: Distribution of Cell Assays Studies Globally, 2018
    • Table 124: Use of Competitive Strategies in the Global Cell Viability Assay Market, 2015 and 2018
    • Table 125: AAT Bioquest Inc.: Product Portfolio
    • Table 126: ABCAM: Product Portfolio
    • Table 127: ABCAM: Recent Developments
    • Table 128: Abnova: Product Portfolio
    • Table 129: Abnova: Recent Developments, 2015-2018
    • Table 130: AnaSpec Inc.: Product Portfolio
    • Table 131: AnaSpec Inc.: Recent Developments
    • Table 132: Becton, Dickinson and Co.: Product Portfolio
    • Table 133: Becton, Dickinson and Co.: Recent Developments
    • Table 134: Bio-Rad Laboratories: Product Portfolio
    • Table 135: Bio-Rad Laboratories: Recent Developments
    • Table 136: BioTek Instruments Inc.: Product Portfolio
    • Table 137: BioTek Instruments Inc.: Developments, April 2016-October 2018
    • Table 138: Biotium: Product Portfolio
    • Table 139: BioVision Inc.: Product Portfolio
    • Table 140: Cayman Chemical: Product Portfolio
    • Table 141: Cayman Chemical: Recent Developments
    • Table 142: Corning Inc.: Product Portfolio
    • Table 143: Creative Bioarray: Product Portfolio
    • Table 144: Danaher Corp.: Product Portfolio
    • Table 145: Danaher Corp.: Recent Developments
    • Table 146: Dojindo Molecular Technologies Inc.: Product Portfolio
    • Table 147: GE Healthcare: Product Portfolio
    • Table 148: Intellicyt Corp.: Product Portfolio
    • Table 149: Intellicyt Corp.: Recent Developments
    • Table 150: Merck KGAA: Product Portfolio
    • Table 151: Merck KGAA: Recent Developments
    • Table 152: MesGen: Product Portfolio
    • Table 153: Molecular Devices LLC: Product Portfolio
    • Table 154: Molecular Devices LLC: Recent Developments
    • Table 155: PerkinElmer Inc.: Product Portfolio
    • Table 156: Promega Corp.: Product Portfolio
    • Table 157: R&D Systems Inc.: Product Portfolio
    • Table 158: Takara Bio Inc.: Product Portfolio
    • Table 159: Takara Bio Inc.: Recent Developments
    • Table 160: Thermo Fisher Scientific: Product Portfolio
    • Table 161: VitaScientific: Product Portfolio

List of Figures

  • Summary Figure: Global Cell Viability Assays Market, by Product, 2017-2023
    • Figure 1: Research Funding for Biological Science Research Studies, 2017
    • Figure 2: Global Tissue Engineering and Cell Therapy Market Growth, 2009-2018
    • Figure 3: Global Projections for Deaths from the Top Three Chronic Diseases, 2005-2030
    • Figure 4: Worldwide Cancer Incidence Rate, by Type, 2018
    • Figure 5: Global Pharmaceutical R&D Spending, 2015-2022
    • Figure 6: Pharmaceutical Research and Manufacturers of America Member Company R&D Expenditures, 2010 and 2016
    • Figure 7: Cell Viability Assays Market, by Product
    • Figure 8: Types of Automated Cell Counters
    • Figure 9: dPCR used for Viability of Genetically Modified Organisms (GMOs)
    • Figure 10: Types of Consumables in the Cell Viability Assays Market
    • Figure 11: Classification of Assay kits
    • Figure 12: Conversion of Resazurin to Resorufin to Determine Cell Viability
    • Figure 13: Protease Activity Assays
    • Figure 14: Global Deaths Due to Cancer, 2018
    • Figure 15: Global Oncology Therapeutics Investment, 2011-2021
    • Figure 16: Approaches for Bacterial Viability Assessment
    • Figure 17: PMA-qPCR Assay and PMA treatment
    • Figure 18: Major Growth Factors of Global Cell Viability Assays Market, by Application
    • Figure 19: Cell Viability Assay Products Used in Clinical and Diagnostics Application
    • Figure 20: Global Cancer Burden, 2012 and 2030
    • Figure 21: Global Prevalence of Dementia, 2015-2050
    • Figure 22: Evaluation of Cell Viability Using Flow Cytometry Technique
    • Figure 23: Global Pharmaceutical Market, 2015 and 2020
    • Figure 24: Pharmaceutical Spending as a Percentage of Health Spending, 2016
    • Figure 25: Global Biologics Spending, 2011 and 2016
    • Figure 26: Global Total of Pharmaceutical R&D Spending, 2015-2022
    • Figure 27: Classification of Stem Cells
    • Figure 28: NIH Spending on Stem Cell Research, 2014-2018 (Estimated)
    • Figure 29: Growing Investment in Different Stem Cell-Based Research in the United States, 2016 and 2017
    • Figure 30: Rise in R&D Expenditures in 2018 Compared with 2017
    • Figure 31: Global Spending on Life Sciences R&D, 2015-2018
    • Figure 32: Top R&D Spending Nations in Europe, 2017 and 2018
    • Figure 33: Investment in Research and Innovation Through European Commission Framework Programs, 1984-2027
    • Figure 34: Number of Research Grants Received by European Countries, 2018
    • Figure 35: R&D Expenditures of the Top 20 Countries in Asia, 2017 and 2018
    • Figure 36: Cell Viability Assays End Users
    • Figure 37: Major Factors Driving Growth of the Cell Viability Assays Market
    • Figure 38: Generalized Scheme Representing an In Vitro Cytotoxicity Assay Protocol
    • Figure 39: Methods of Cell Viability Counting Used in Research Institutions
    • Figure 40: Usage of Flow Cytometry in the Drug Discovery and Development Process
    • Figure 41: U.S. Pharmaceutical R&D Spending, 2005-2015
    • Figure 42: R&D Spending by India's Seven Largest Pharma Companies, 2016
    • Figure 43: Death Rates Due to Cancer, 2018
    • Figure 44: People Infected with HIV, by Region, 2014-2016
    • Figure 45: Malaria Deaths, by Region, 2014-2016
    • Figure 46: NIH Spending on Stem Cell Research, 2013-2016
    • Figure 47: Healthcare Expenditures in Canada, 2015 and 2040
    • Figure 48: Distribution of Annual Budget of Canadian Institute of Health Research, 2016
    • Figure 49: Estimated Number of People Living with Cancer in the U.K., 2015 vs. 2020
    • Figure 50: Government Funding for Drug-Based Research in France, 2010 and 2016
    • Figure 51: Rising Number of Cancer Cases in Spain, 2012 and 2015
    • Figure 52: Hospitals and Research Centers Participating in Clinical Trials on Cancer, 2004-2016
    • Figure 53: Rising Prevalence of Breast Cancer in Norway, 2014 and 2015
    • Figure 54: Number of People with Cancer in China, 2010-2016
    • Figure 55: Japanese Pharmaceuticals Industry, 2010-2015
    • Figure 56: R&D Spending by Top Seven Pharmaceutical Companies in India, 2018
    • Figure 57: Overall ROW R&D Expenditures, by Region, 2016 and 2017
    • Figure 58: Deaths in Brazil Due to Cancer, 2010 and 2016
    • Figure 59: Capital Raised by Israeli High-Tech Companies, 2013-2017
    • Figure 60: Industry Structure of Instruments Used in Cell Viability Assays Market
    • Figure 61: Industry Structure of Consumables Used in the Cell Viability Assays Market
    • Figure 62: Distribution of Cell Assays Studies Globally, 2018
    • Figure 63: Competitive Strategies Used in the Global Cell Viability Assay Market, 2015 and 2018
Back to Top